Population Pharmacokinetics of Polymyxin B in Acutely Ill Adult Patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Population Pharmacokinetics of Polymyxin B in Acutely Ill Adult Patients
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 62, Issue 3, Pages -
Publisher
American Society for Microbiology
Online
2018-01-06
DOI
10.1128/aac.01475-17
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population Pharmacokinetics of Intravenous Polymyxin B from Clinical Samples
- (2018) Christine J. Kubin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B
- (2016) Maria Helena Rigatto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dosing guidance for intravenous colistin in critically-ill patients
- (2016) Roger L Nation et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
- (2016) Thien B. Tran et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study
- (2015) Maria Helena Rigatto et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- New pharmacokinetic/pharmacodynamic studies of systemically administered colistin againstPseudomonas aeruginosaandAcinetobacter baumanniiin mouse thigh and lung infection models: smaller response in lung infection
- (2015) Soon-Ee Cheah et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy
- (2014) K. Phe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymyxin B Dosing in Obese and Underweight Adults
- (2013) M. P. Pai CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
- (2013) Ana M. Sandri et al. CLINICAL INFECTIOUS DISEASES
- Higher Incidence of Acute Kidney Injury With Intravenous Colistimethate Sodium Compared With Polymyxin B in Critically Ill Patients at a Tertiary Care Medical Center
- (2013) Darowan S. Akajagbor et al. CLINICAL INFECTIOUS DISEASES
- Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium
- (2013) Felipe F. Tuon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy
- (2012) Christine J. Kubin et al. JOURNAL OF INFECTION
- High Performance Liquid Chromatography–Mass Spectrometry Assay for Polymyxin B1 and B2 in Human Plasma
- (2012) Tiffany A. Thomas et al. THERAPEUTIC DRUG MONITORING
- Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R
- (2012) Michael N. Neely et al. THERAPEUTIC DRUG MONITORING
- fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models
- (2010) R. V. Dudhani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
- (2010) Lauren M Lim et al. PHARMACOTHERAPY
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
- (2009) D. Plachouras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin in the 21st century
- (2009) Roger L Nation et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections
- (2007) Andrea L.H. Kwa et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started